AIG
CLCD

American International Group’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

American International Group’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-750
Closed -$5K – 4920
2016
Q1 		$5K Hold
750
– – ﹤0.01% 4748
2015
Q4 		$6K Hold
750
– – ﹤0.01% 4675
2015
Q3 		$3K Buy
+750
New +$5.54K ﹤0.01% 4786

Other funds holding CLCD

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
SG
Societe Generale $14.1B AUM
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

American International Group's CLCD Position: Q2 2016 in Review

American International Group sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q2 2016, closing a stake of 750 shares — an estimated $5K sold.

American International Group first reported a position in CLCD in Q3 2015 and held it in 3 quarters. The position peaked at $6K in Q4 2015. 20 funds tracked by Wall St. Rank hold CLCD as of Q2 2016.

  • American International Group reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 750 CoLucid Pharmaceuticals, Inc. shares in Q2 2016, an estimated $5K.
  • American International Group first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
  • American International Group's CoLucid Pharmaceuticals, Inc. position peaked at $6K in Q4 2015.
  • 20 funds tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.